查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1623447

全球无晶体眼市场规模（按类型、治疗、最终用户、地区、范围和预测）

Global Aphakia Market Size By Type (Congenital Aphakia, Surgical Aphakia), By Treatment (Spectacles, Contact Lenses), By End User (Hospitals, Ophthalmic clinics), By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

无晶体眼的市场规模及预测

无晶体眼市场规模预计在 2024 年达到 18.3 亿美元，到 2031 年将达到 43 亿美元，在 2024-2031 年预测期内的复合年增长率为 11.3%。由于人口老化、医疗保健行业蓬勃发展以及对更好的眼疾治疗的需求不断增加，市场正在成长。本报告对全球无晶体眼市场进行了全面的评估。它对关键细分市场、趋势、市场推动因素、阻碍因素、竞争格局以及在市场中发挥关键作用的因素进行了全面的分析。

定义全球无水晶体眼市场

无晶体眼是指眼内没有水晶体，可能是因为水晶体已经由手术摘除，或因为出生时水晶体不存在。水晶体是眼睛内部的透明结构，有助于将光线聚焦到眼睛后部的视网膜上。如果没有镜片，视力就会严重受损，造成严重的视力伤害。无晶体症可能由多种原因引起，包括白内障手术、先天性水晶体缺失、外伤或感染。

可以透过手术摘除天然水晶体，并以人工水晶体取代。然而，在某些情况下，例如患有先天性无晶体症的人，无法使用人工水晶体，人们必须依靠矫正镜片或其他装置来改善视力。无晶体眼患者往往有严重的屈光不正，包括严重的近视、远视和散光。

通常，医生会建议使用矫正镜片（例如眼镜或隐形眼镜）来改善视力。在某些情况下，可能会建议使用称为无晶体眼的特殊隐形眼镜。儘管无晶体眼对视力有严重影响，但许多人在矫正镜片和其他设备的帮助下能够过正常、富有成效的生活。对于无晶体眼患者，定期进行眼科检查非常重要，以监测视力并确保矫正镜片是最新的。

全球无晶体眼市场概况

无晶体眼市场是指提供与无水晶体眼治疗相关的产品和服务的产业。该市场包括矫正镜片、人工镜片等产品，以及有助于改善无晶体眼患者视力的其他设备。无晶体眼治疗市场的发展主要受到白内障手术日益普及的推动，白内障手术是无晶体眼最常见的原因。

随着人口老化和白内障手术数量的增加，无晶体眼护理相关产品和服务的需求预计会增加。无晶体眼治疗市场也受到先进技术和创新产品成长的推动。例如，新型人工水晶体（如人工水晶体（IOL））的开发改善了白内障手术的结果并为无晶体眼患者提供了新的选择。

总体而言，由于对无晶体眼和相关疾病的治疗方案的需求不断增加，无晶体眼市场预计未来将继续增长。技术上的创新和进步可能会推动市场向前发展，为无晶体眼患者的视力和生活品质改善提供新的选择和机会。

市场吸引力

透过提供市场吸引力的影像，您可以获得有关领先全球无晶体眼科市场的地区的资讯。我们涵盖了推动指定区域产业成长的主要影响因素。

波特五力模型

波特五力框架为理解竞争对手的行为和每个产业参与者的策略定位提供了蓝图。波特五力模型可用于评估全球无水晶体眼市场的竞争格局、衡量特定细分市场的吸引力以及评估投资潜力。

目录

第 1 章 全球无晶体眼市场：简介

    市场概况
  • 研究范围
  • 先决条件

第 2 章执行摘要

第 3 章：经过验证的市场研究方法

  • 资料探勘
  • 验证
  • 主要来源
  • 资料来源列表

第 4 章 全球无晶体眼市场展望

  • 概述
  • 市场动态
    • 驱动程式
    • 阻碍因素
    • 机会
  • 波特五力模型
  • 价值链分析

第 5 章全球无晶体眼市场类型
  • 概述
  • 先天性无晶体
  • 手术性无晶体症
  • 后天性无晶体

第6章全球无水晶体眼市场（依治疗方法）

  • 概述
  • 眼镜
  • 隐形眼镜
  • 人工水晶体植入
  • 屈光手术

第7章全球无水晶体眼市场（依最终用户划分）

  • 概述
  • 医院
  • 眼科诊所
  • 其他

第 8 章 全球无晶体眼市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲国家
    亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 世界其他地区
    • 拉丁美洲
    • 中东和非洲

第 9 章 全球无水晶体眼市场：竞争格局

  • 概述
  • 各公司的市场排名
  • 主要发展策略

第10章 公司简介

  • Johnson & Johnson Services, Inc.
  • Ophtec BV
  • Novartis AG
  • Bausch Health
  • ZEISS International.
  • Rayner Intraocular Lenses Limited
  • Aetna Inc.
  • CooperVision
  • Menicon Co.Ltd.
  • Labtician Ophthalmics, Inc.

第 11 章 重大进展

  • 产品发布/开发
  • 合併和收购
  • 业务扩展
  • 伙伴关係和合作关係

第 12 章附录

  • 相关研究
简介目录
Product Code: 23692

Aphakia Market Size And Forecast

Aphakia Market size was valued at USD 1.83 Billion in 2024 and is projected to reach USD 4.30 Billion by 2031, growing at a CAGR of 11.3% during the forecast period 2024-2031. The market is growing as a result of the aging population, the quickly growing healthcare industry, and the rising demand for better ocular disease treatment. The Global Aphakia Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors playing a substantial role in the market.

Global Aphakia Market Definition

Aphakia is a condition in which a person's eye is missing its natural lens, either because it was surgically removed or because it was never present at birth. The lens is the transparent structure inside the eye that helps to focus light onto the retina at the back of the eye. Without a lens, vision can be severely impaired, causing significant visual problems. Aphakia can result from various causes, including cataract surgery, congenital absence of the lens, trauma, or infection.

When the natural lens is removed surgically, an artificial lens can be implanted to replace it. However, in some cases, such as with congenital aphakia, an artificial lens may not be an option, and the person may need to rely on corrective lenses or other devices to improve their vision. People with aphakia often have significant refractive errors, such as high degrees of nearsightedness or farsightedness, and astigmatism.

Corrective lenses, such as glasses or contact lenses, are often prescribed to help improve vision. In some cases, a special type of contact lens called an aphakic lens may be recommended, which is designed to compensate for the lack of a natural lens. While vision can be significantly affected by aphakia, many people with the condition are able to lead normal, productive lives with the help of corrective lenses or other devices. Regular eye exams are important for people with aphakia to monitor their vision and ensure that their corrective lenses are up to date.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Aphakia Market Overview

The Aphakia Market refers to the industry that provides products and services related to the treatment of the condition known as aphakia, in which a person's natural lens is missing from their eye. The market includes products such as corrective lenses, artificial lenses, and other devices that can help improve vision in people with aphakia. The market for aphakia treatment is primarily driven by the increasing prevalence of cataract surgery, which is the most common cause of aphakia.

As the population ages and the number of cataract surgeries performed increases, the demand for products and services related to aphakia treatment is expected to grow. The market for aphakia treatment is also driven by the increasing availability of advanced technology and innovative products. For example, the development of new types of artificial lenses, such as intraocular lenses (IOLs), has improved the outcomes of cataract surgery and provided new options for people with aphakia.

Overall, the Aphakia Market is expected to continue to grow in the coming years as the demand for treatment options for aphakia and related conditions increases. New innovations and advancements in technology are likely to drive the market forward, providing new options and opportunities for people with aphakia to improve their vision and quality of life.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Aphakia Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.

Porter's Five Forces

The image provided would further help to get information about Porter's five forces framework providing a blueprint for understanding the behavior of competitors and a player's strategic positioning in the respective industry. Porter's five forces model can be used to assess the competitive landscape in the Global Aphakia Market, gauge the attractiveness of a certain sector, and assess investment possibilities.

Global Aphakia Market Segmentation Analysis

The Global Aphakia Market is segmented on the basis of Type, Treatment, End User, and Geography.

Aphakia Market, By Type

  • Congenital Aphakia
  • Surgical Aphakia
  • Acquired Aphakia

Based on Type, the Aphakia Market is segmented into Congenital Aphakia, Surgical Aphakia, and Acquired Aphakia. Acquired Aphakia is a condition brought on by the absence of eye lenses. This disorder can affect people of any age, but it usually develops as a result of an accident, a procedure, or an illness such as osteogenesis imperfecta or glaucoma. Patients without a lens or its remnant are reported to have this kind of aphakia. Double vision and hazy vision are two of the signs of this type, while additional signs include cataract surgery, refractive surgery, etc.

Aphakia Market, By Treatment

  • Spectacles
  • Contact Lenses
  • Intraocular Lens Implantation
  • Refractive Surgery

Based on Treatment, the Aphakia Market is segmented into Spectacles, Contact Lenses, Intraocular Lens Implantation, and Refractive Surgery. When the natural lens of an eye gets foggy and cannot be corrected by regular glasses, aphakia is employed. This allows for a clean vision of objects that are different distances from the eyes. Once such treatment has been received, an aphakia patient will no longer require the use of any extra reading or near-vision lenses.

Aphakia Market, By End User

  • Hospitals
  • Ophthalmic clinics
  • Others

Based on End User, the Aphakia Market is segmented into Hospitals, Ophthalmic clinics, and Others.

Aphakia Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
  • On the basis of Regional Analysis, The Global Aphakia Market is classified into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Due to the rising prevalence of aphakia cases, advanced technology, the region's sizable diabetic population, and increased government funding for R&D, North America dominates the global aphakia industry. Because of its substantial and fast-expanding economy, sizable patient pool, rising frequency of ocular illnesses, and rapidly rising elderly population, Asia-Pacific is predicted to develop at a significant growth rate in the forecast period.

Key Players

  • The "Global Aphakia Market" study report will provide valuable insight with an emphasis on the Global market including some of the major key players such as
  • Johnson & Johnson Services, Inc., Ophtec BV, Novartis AG, Bausch Health, ZEISS International, Rayner Intraocular Lenses Limited, Aetna Inc., CooperVision, Menicon Co., Ltd., Labtician Ophthalmics, Inc., and Others.

Our market analysis contains a section exclusively devoted to such significant firms, where our experts provide a summary of each company's financial statements as well as product benchmarking and SWOT analysis. The competitive landscape section also includes the key development strategies, market share analysis, and market positioning analysis of the aforementioned competitors internationally.

Key Developments

  • In July 2022, Intraocular lenses (IOLs) from the Clareon(R)family have been made available in the United States, according to Alcon (SIX/NYSE: ALC), a leader in eye care around the world committed to enabling people to see brilliantly. The most cutting-edge IOL material from Alcon allows Clareon to produce consistently excellent visual results and long-lasting clarity. 1-7 When compared to the leading competitor IOLs, the glistening-free IOL material used in Clareon has some of the lowest levels of haze and subsurface nanoglistenings (SSNGs).
  • Ace Matrix Analysis
  • The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as
  • Active, Cutting Edge, Emerging, and Innovators.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL APHAKIA MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL APHAKIA MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL APHAKIA MARKET, BY TYPE

  • 5.1 Overview
  • 5.2 Congenital Aphakia
  • 5.3 Surgical Aphakia
  • 5.4 Acquired Aphakia

6 GLOBAL APHAKIA MARKET, BY TREATMENT

  • 6.1 Overview
  • 6.2 Spectacles
  • 6.3 Contact Lenses
  • 6.4 Intraocular Lens Implantation
  • 6.5 Refractive Surgery

7 GLOBAL APHAKIA MARKET, BY END USER

  • 7.1 Overview
  • 7.2 Hospitals
  • 7.3 Ophthalmic Clinics
  • 7.4 Others

8 GLOBAL APHAKIA MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East & Africa

9 GLOBAL APHAKIA MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 Johnson & Johnson Services, Inc.
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Ophtec BV
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 Novartis AG
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 Bausch Health
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 ZEISS International.
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 Rayner Intraocular Lenses Limited
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 Aetna Inc.
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 CooperVision
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 Menicon Co.Ltd.
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Developments
  • 10.10 Labtician Ophthalmics, Inc.
    • 10.10.1 Overview
    • 10.10.2 Financial Performance
    • 10.10.3 Product Outlook
    • 10.10.4 Key Developments

11 KEY DEVELOPMENTS

  • 11.1 Product Launches/Developments
  • 11.2 Mergers and Acquisitions
  • 11.3 Business Expansions
  • 11.4 Partnerships and Collaborations

12 Appendix

  • 12.1 Related Research